SC
MIRM icon

SouthState Corp’s Mirum Pharmaceuticals MIRM Stock Holding History

SouthState Corp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48
Closed -$2.44K – 1494
2025
Q2 		$2.44K Hold
48
– – ﹤0.01% 1055
2025
Q1 		$2.16K Buy
+48
New +$2.26K ﹤0.01% 1178

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SouthState Corp's MIRM Position: Q3 2025 in Review

SouthState Corp sold out of Mirum Pharmaceuticals (MIRM) in Q3 2025, closing a stake of 48 shares — an estimated $2.44K sold.

SouthState Corp first reported a position in MIRM in Q1 2025 and held it in 2 quarters. The position peaked at $2.44K in Q2 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • SouthState Corp reported no remaining Mirum Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • SouthState Corp sold 48 Mirum Pharmaceuticals shares in Q3 2025, an estimated $2.44K.
  • SouthState Corp first reported a position in Mirum Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • SouthState Corp's Mirum Pharmaceuticals position peaked at $2.44K in Q2 2025.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.